Active Nonsegmental Vitiligo

News

March 12, 2024

3 min read

Save

New data show ritlecitinib plus phototherapy beneficial for nonsegmental vitiligo

SAN DIEGO — In patients with active nonsegmental vitiligo, ritlecitinib monotherapy or paired with twice weekly narrowband ultraviolet B phototherapy improved facial and total body repigmentation, according to a speaker here.

News

January 13, 2024

1 min read

Save

Early trial results of VYN201 show success in vitiligo

VYN201 showed positive effects on biomarkers of vitiligo in a phase 1b trial, VYNE Therapeutics announced in a press release.